Market Cap 671.64M
Revenue (ttm) 0.00
Net Income (ttm) -3.35M
EPS (ttm) N/A
PE Ratio 4.32
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -2.16
Volume 1,375,600
Avg Vol 1,900,646
Day's Range N/A - N/A
Shares Out 72.38M
Stochastic %K 55%
Beta 2.55
Analysts Strong Sell
Price Target $44.00

Company Profile

Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases. The company's lead products candidate is the Narsoplimab (OMS721/MASP-2) for the treatment of hematopoietic stem-cell transplant-associated thrombotic microangiopathy (TA-TMA); and in Phase II clinical trial to treat COVID-19 and acute respiratory distress syndrome. It also develops OMS1029 that has...

Industry: Biotechnology
Sector: Healthcare
Phone: 206 676 5000
Address:
The Omeros Building, 201 Elliott Avenue West, Seattle, United States
stockpimpbot5000
stockpimpbot5000 Jul. 4 at 6:43 PM
$OMER Have an amazing Independence Day to all 'mericans! 😎
0 · Reply
Arad288
Arad288 Jul. 4 at 11:20 AM
$OMER Happy 250th anniversary America We are blessed to live in this country
1 · Reply
naturegirl669
naturegirl669 Jul. 3 at 10:41 PM
$OMER - "Hematopoietic Stem Cell Transplantation Market Size, Share and Trends 2026 to 2035" https://www.precedenceresearch.com/hematopoietic-stem-cell-transplantation-market
0 · Reply
Benalish
Benalish Jul. 3 at 4:23 PM
$OMER looks like reverse head and shoulders on the daily chart
0 · Reply
gogosingkorean
gogosingkorean Jul. 3 at 3:22 PM
$OMER I really wonder the job
2 · Reply
LeaLeb
LeaLeb Jul. 3 at 12:52 PM
$OMER While biotechs and $XBI are having one of the best runs in history, OMER is still underwater and undervalued, may we have a better second half of 2026 that we had the first half and finally get going higher to justified value. Enjoy the omercoaster huge climb ahead for the OMER fam on the coaster. Happy Independence Day y'all!
1 · Reply
gogosingkorean
gogosingkorean Jul. 3 at 4:14 AM
$OMER anyone knows gergs birthday?
0 · Reply
bentley99
bentley99 Jul. 3 at 2:37 AM
$VRDN Sorry I'm late. Love AI search. $OMER and $ABEO folks see this and $TARS
1 · Reply
Benalish
Benalish Jul. 3 at 1:07 AM
1 · Reply
Benalish
Benalish Jul. 3 at 12:13 AM
$OMER Maybe the frivolous lawsuit will give Greg a kick in the nuts!
0 · Reply
Latest News on OMER
Omeros stock crashes on regulatory setback: buy the dip?

Jun 26, 2026, 2:11 PM EDT - 8 days ago

Omeros stock crashes on regulatory setback: buy the dip?


Omeros Transcript: AGM 2026

Jun 18, 2026, 1:00 PM EDT - 16 days ago

Omeros Transcript: AGM 2026


Omeros trading resumes

2026-06-12T13:45:42.000Z - 22 days ago

Omeros trading resumes


Omeros trading halted, volatility trading pause

2026-06-12T13:35:42.000Z - 22 days ago

Omeros trading halted, volatility trading pause


Omeros Earnings Call Transcript: Q1 2026

May 13, 2026, 4:30 PM EDT - 7 weeks ago

Omeros Earnings Call Transcript: Q1 2026


Omeros Earnings release: Q1 2026

May 13, 2026, 4:30 PM EDT - 7 weeks ago

Omeros Earnings release: Q1 2026


Omeros Quarterly report: Q1 2026

May 13, 2026, 4:30 PM EDT - 7 weeks ago

Omeros Quarterly report: Q1 2026


Omeros reports Q1 adjusted EPS (24c), consensus (28c)

2026-05-13T20:27:08.000Z - 7 weeks ago

Omeros reports Q1 adjusted EPS (24c), consensus (28c)


Omeros Corporation Reports First Quarter 2026 Financial Results

May 13, 2026, 4:02 PM EDT - 7 weeks ago

Omeros Corporation Reports First Quarter 2026 Financial Results


Omeros Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 2 months ago

Omeros Proxy statement: Proxy filing


Omeros Earnings Call Transcript: Q4 2025

Mar 31, 2026, 4:30 PM EDT - 3 months ago

Omeros Earnings Call Transcript: Q4 2025


Omeros Earnings release: Q4 2025

Mar 31, 2026, 4:30 PM EDT - 3 months ago

Omeros Earnings release: Q4 2025


Omeros Annual report: Q4 2025

Mar 31, 2026, 4:30 PM EDT - 3 months ago

Omeros Annual report: Q4 2025


Omeros reports Q4 EPS $1.22, consensus 36c

2026-03-31T20:05:48.000Z - 3 months ago

Omeros reports Q4 EPS $1.22, consensus 36c


Omeros announces first commercial sales of Yartemlea

2026-01-27T14:20:24.000Z - 5 months ago

Omeros announces first commercial sales of Yartemlea


Omeros Announces First Commercial Sales of YARTEMLEA®

Jan 27, 2026, 9:00 AM EST - 5 months ago

Omeros Announces First Commercial Sales of YARTEMLEA®


Omeros price target raised to $40 from $20 at H.C. Wainwright

2026-01-08T11:11:35.000Z - 6 months ago

Omeros price target raised to $40 from $20 at H.C. Wainwright


Omeros prices transplant complication drug at $36,000 per dose

Jan 7, 2026, 6:50 PM EST - 6 months ago

Omeros prices transplant complication drug at $36,000 per dose


Omeros Transcript: FDA Announcement

Jan 7, 2026, 4:30 PM EST - 6 months ago

Omeros Transcript: FDA Announcement


Omeros Press release: FDA Announcement

Jan 7, 2026, 4:30 PM EST - 6 months ago

Omeros Press release: FDA Announcement


Omeros trading resumes

2025-12-24T15:15:15.000Z - 6 months ago

Omeros trading resumes


Omeros trading halted, volatility trading pause

2025-12-24T15:10:19.000Z - 6 months ago

Omeros trading halted, volatility trading pause


Omeros Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 8 months ago

Omeros Earnings Call Transcript: Q3 2025


Omeros Quarterly report: Q3 2025

Nov 13, 2025, 4:30 PM EST - 8 months ago

Omeros Quarterly report: Q3 2025


Omeros Earnings release: Q3 2025

Nov 13, 2025, 4:30 PM EST - 8 months ago

Omeros Earnings release: Q3 2025


Omeros Corporation Reports Third Quarter 2025 Financial Results

Nov 13, 2025, 4:11 PM EST - 8 months ago

Omeros Corporation Reports Third Quarter 2025 Financial Results


Omeros Earnings Call Transcript: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 11 months ago

Omeros Earnings Call Transcript: Q2 2025


Omeros Quarterly report: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 11 months ago

Omeros Quarterly report: Q2 2025


Omeros Earnings release: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 11 months ago

Omeros Earnings release: Q2 2025


Omeros Corporation Reports Second Quarter 2025 Financial Results

Aug 14, 2025, 4:02 PM EDT - 11 months ago

Omeros Corporation Reports Second Quarter 2025 Financial Results


Omeros Proxy statement: Proxy Filing

May 30, 2025, 8:00 AM EDT - 1 year ago

Omeros Proxy statement: Proxy Filing


Omeros Earnings Call Transcript: Q1 2025

May 15, 2025, 4:30 PM EDT - 1 year ago

Omeros Earnings Call Transcript: Q1 2025


Omeros Quarterly report: Q1 2025

May 15, 2025, 4:30 PM EDT - 1 year ago

Omeros Quarterly report: Q1 2025


Omeros Earnings release: Q1 2025

May 15, 2025, 4:30 PM EDT - 1 year ago

Omeros Earnings release: Q1 2025


Omeros Earnings Call Transcript: Q4 2024

Mar 31, 2025, 4:30 PM EDT - 1 year ago

Omeros Earnings Call Transcript: Q4 2024


Omeros Annual report: Q4 2024

Mar 31, 2025, 4:30 PM EDT - 1 year ago

Omeros Annual report: Q4 2024


Omeros Earnings release: Q4 2024

Mar 31, 2025, 4:30 PM EDT - 1 year ago

Omeros Earnings release: Q4 2024


Omeros Earnings Call Transcript: Q3 2024

Nov 13, 2024, 4:30 PM EST - 1 year ago

Omeros Earnings Call Transcript: Q3 2024


Omeros Earnings release: Q3 2024

Nov 13, 2024, 4:30 PM EST - 1 year ago

Omeros Earnings release: Q3 2024


Omeros Quarterly report: Q3 2024

Nov 13, 2024, 4:30 PM EST - 1 year ago

Omeros Quarterly report: Q3 2024


Omeros Earnings Call Transcript: Q2 2024

Aug 7, 2024, 4:30 PM EDT - 2 years ago

Omeros Earnings Call Transcript: Q2 2024


Omeros Quarterly report: Q2 2024

Aug 7, 2024, 4:30 PM EDT - 2 years ago

Omeros Quarterly report: Q2 2024


Omeros Earnings release: Q2 2024

Aug 7, 2024, 4:30 PM EDT - 2 years ago

Omeros Earnings release: Q2 2024


stockpimpbot5000
stockpimpbot5000 Jul. 4 at 6:43 PM
$OMER Have an amazing Independence Day to all 'mericans! 😎
0 · Reply
Arad288
Arad288 Jul. 4 at 11:20 AM
$OMER Happy 250th anniversary America We are blessed to live in this country
1 · Reply
naturegirl669
naturegirl669 Jul. 3 at 10:41 PM
$OMER - "Hematopoietic Stem Cell Transplantation Market Size, Share and Trends 2026 to 2035" https://www.precedenceresearch.com/hematopoietic-stem-cell-transplantation-market
0 · Reply
Benalish
Benalish Jul. 3 at 4:23 PM
$OMER looks like reverse head and shoulders on the daily chart
0 · Reply
gogosingkorean
gogosingkorean Jul. 3 at 3:22 PM
$OMER I really wonder the job
2 · Reply
LeaLeb
LeaLeb Jul. 3 at 12:52 PM
$OMER While biotechs and $XBI are having one of the best runs in history, OMER is still underwater and undervalued, may we have a better second half of 2026 that we had the first half and finally get going higher to justified value. Enjoy the omercoaster huge climb ahead for the OMER fam on the coaster. Happy Independence Day y'all!
1 · Reply
gogosingkorean
gogosingkorean Jul. 3 at 4:14 AM
$OMER anyone knows gergs birthday?
0 · Reply
bentley99
bentley99 Jul. 3 at 2:37 AM
$VRDN Sorry I'm late. Love AI search. $OMER and $ABEO folks see this and $TARS
1 · Reply
Benalish
Benalish Jul. 3 at 1:07 AM
1 · Reply
Benalish
Benalish Jul. 3 at 12:13 AM
$OMER Maybe the frivolous lawsuit will give Greg a kick in the nuts!
0 · Reply
delfinozavala
delfinozavala Jul. 2 at 10:10 PM
$OMER anyone, why didn’t Omer issue pr on jcode? Why did short interest go up by 2mil as of 15 Jun? Seems like all positive catalysts have been duds. Will we now hit Sp of $20 in 2qtr of next year? Am I only long term bull that’s very disappointed?
1 · Reply
haxhiua1
haxhiua1 Jul. 2 at 10:10 PM
$OMER what is this about? Is it common? https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-omeros-corporation---omer-302816386.html
3 · Reply
BanaT
BanaT Jul. 2 at 9:57 PM
$OMER Happy Independence Day Weekend Everyone ... maybe one day our stock will hit 250 a share.
2 · Reply
gogosingkorean
gogosingkorean Jul. 2 at 8:20 PM
$OMER What is the Oms1029 application's predictive ability? It can create bubbles.
0 · Reply
naturegirl669
naturegirl669 Jul. 2 at 7:36 PM
$OMER - "The FDA permits physicians to prescribe approved drugs or devices for off-label uses—meaning for a different condition, age group, or dosage. Because the FDA does not regulate the practice of medicine, they trust a doctor's clinical judgment to treat patients with medications they deem appropriate." "While physicians have legal freedom to prescribe, the FDA TIGHTLY RESTRICTS how pharmaceutical and medical device companies behave. Companies are LEGALLY PROHIBITED FROM PROMOTING or MARKETING their products for any off-label uses. The agency does not evaluate safety or efficacy for these unapproved uses, and manufacturers cannot make claims about them unless providing specific, peer-reviewed scientific information under strict regulatory guidelines."
0 · Reply
resq1
resq1 Jul. 2 at 7:16 PM
$OMER still trading at 30% of face value
2 · Reply
bentley99
bentley99 Jul. 2 at 7:12 PM
$AKBA AI picked this $ALLR and $IKT as potential moonshots. $UNCY is recovering while waiting on $OMER As an alternate to $OMER AI picked$TARS
0 · Reply
nick39
nick39 Jul. 2 at 6:59 PM
$OMER Get conventional financing and eliminate the remaining convertible overhang while the stock is still depressed.
0 · Reply
Norton850
Norton850 Jul. 2 at 5:32 PM
$OMER I don’t think a buyout by Novo is in Omer’s future. Novo purchased the asset they wanted without having to pay for the rest of Omer’s pipeline. And Omer’s other assets don’t align with Novo’s priorities. Omer’s best, and most likely future, is to remain independent and use Yartemlea sales and Novo royalties to develop its current and future pipeline. Think long term hold 2028 and beyond; that’s the real payoff. CMPX on the other hand is, in my opinion, in play for a buyout in the near future.
3 · Reply
Tyler1100
Tyler1100 Jul. 2 at 4:42 PM
$OMER $NVO whayt would a buyout even look like?
0 · Reply
Benalish
Benalish Jul. 2 at 3:36 PM
$OMER best shot for breakout is buyout from $NVO
1 · Reply
gogosingkorean
gogosingkorean Jul. 2 at 3:21 PM
$OMER what is a near term? I thinknmy eng skill not got so cant understand word near term
2 · Reply